These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7863014)

  • 21. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
    Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
    Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding.
    Cooper SJ; Dourish CT
    Physiol Behav; 1990 Dec; 48(6):849-57. PubMed ID: 1982361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions.
    Rehfeld JF
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin and learning and memory processes.
    Hadjiivanova C; Belcheva S; Belcheva I
    Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder.
    Hamilton SP; Slager SL; Helleby L; Heiman GA; Klein DF; Hodge SE; Weissman MM; Fyer AJ; Knowles JA
    Mol Psychiatry; 2001 Jan; 6(1):59-65. PubMed ID: 11244486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCK agonists and antagonists in clinical studies of panic and anxiety.
    Bradwejn J
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():481A-482A. PubMed ID: 1498920
    [No Abstract]   [Full Text] [Related]  

  • 27. CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder.
    Akiyoshi J; Moriyama T; Isogawa K; Miyamoto M; Sasaki I; Kuga K; Yamamoto H; Yamada K; Fujii I
    J Neurochem; 1996 Apr; 66(4):1610-6. PubMed ID: 8627317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of cholecystokinin system genes in panic disorder.
    Kennedy JL; Bradwejn J; Koszycki D; King N; Crowe R; Vincent J; Fourie O
    Mol Psychiatry; 1999 May; 4(3):284-5. PubMed ID: 10395221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA
    Biol Psychiatry; 1996 Oct; 40(8):804-6. PubMed ID: 8894076
    [No Abstract]   [Full Text] [Related]  

  • 30. Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects.
    Hattori E; Yamada K; Toyota T; Yoshitsugu K; Toru M; Shibuya H; Yoshikawa T
    Am J Med Genet; 2001 Dec; 105(8):779-82. PubMed ID: 11803530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.
    Kramer MS; Cutler NR; Ballenger JC; Patterson WM; Mendels J; Chenault A; Shrivastava R; Matzura-Wolfe D; Lines C; Reines S
    Biol Psychiatry; 1995 Apr; 37(7):462-6. PubMed ID: 7786960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.
    Bradwejn J; Koszycki D; Couëtoux du Tertre A; van Megen H; den Boer J; Westenberg H
    Arch Gen Psychiatry; 1994 Jun; 51(6):486-93. PubMed ID: 8192551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cholecystokinin type B receptors in ultrasound induced behavior in rats.
    Voits M; Beckett SR; Marsden CA; Fink H
    Peptides; 1999; 20(3):383-6. PubMed ID: 10447098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Adams JB; Pyke RE; Costa J; Cutler NR; Schweizer E; Wilcox CS; Wisselink PG; Greiner M; Pierce MW; Pande AC
    J Clin Psychopharmacol; 1995 Dec; 15(6):428-34. PubMed ID: 8748432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin in the entero-insular axis.
    Okabayashi Y; Otsuki M; Baba S
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S79-85. PubMed ID: 2680370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA; Blanchard JC
    Therapie; 1992 Nov; 47(6):541-8. PubMed ID: 1301646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.